Mechanisms of disease: Mechanism-based classification of neuropathic pain - A critical analysis

Nature Clinical Practice Neurology

Volumn 2, Issue 2, 2006, Pages 107-115

  Finnerup, Nanna B ^a   Jensen, Troels S ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Allodynia; Mechanism based classification; Neurophatic pain

Indexed keywords

ALFENTANIL; FENTANYL; KETAMINE; LAMOTRIGINE; LIDOCAINE; MEXILETINE; MORPHINE; NORADRENALIN UPTAKE INHIBITOR; OXYCODONE; PHENTOLAMINE; PROPOFOL; SEROTONIN UPTAKE INHIBITOR; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

CELL METABOLISM; CLINICAL FEATURE; CLINICAL PRACTICE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DRUG MECHANISM; DRUG TARGETING; HUMAN; MOLECULAR MECHANICS; NERVE INJURY; NEUROBIOLOGY; NEUROPATHIC PAIN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SYMPTOMATOLOGY; VALIDATION PROCESS;

ANALGESICS; CENTRAL NERVOUS SYSTEM; HUMANS; NEURALGIA; PERIPHERAL NERVES; RESEARCH DESIGN;

EID: 32244431599     PISSN: 1745834X     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncpneuro0118     Document Type: Review

References (84)

1. McQuay and Moore (1998) An evidence based resource for pain relief. Oxford: Oxford University Press
2. Finnerup NB et al. (2005) Algorithm for neuropathic pain treatment: An evidence based proposal. Pain 118: 289-305
3. Baron R (2006) Mechanisms of Disease: Neuropathic pain - a clinical perspective. Nat Clin Pract Neurol 2: 95-106
4. Jensen TS and Baron R (2003) Translation of symptoms and signs into mechanisms in neuropathic pain. Pain 102: 1-8
5. Farrar JT et al. (2001) Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 94: 149-158
6. Rasmussen PV et al. (2004) Symptoms and signs in patients with suspected neuropathic pain. Pain 110: 461-469
7. Bouhassira D et al. (2005) Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 114: 29-36
8. Bennett M (2001) The LANSS Pain Scale: The Leeds assessment of neuropathic symptoms and signs. Pain 92: 147-157
9. Krause SJ and Backonja M (2003) Development of a neuropathic pain questionnaire. Clin J Pain 19: 306-314
10. Perkins FM et al. (2004) Development and validation of a brief, descriptive Danish pain questionnaire (BDDPQ). Acta Anaesthesiol Scand 48: 486-490
11. Rasmussen PV et al. (2004) Therapeutic outcome in neuropathic pain: relationship to evidence of nervous system lesion. Eur J Neurol 11: 545-553
12. Besson JM (1999) The neurobiology of pain. Lancet 353: 1610-1615
13. Julius D and Basbaum AI (2001) Molecular mechanisms of nociception. Nature 413: 203-210
14. Watkins LR et al. (2001) Spinal cord glia: New players in pain. Pain 93: 201-205
15. Mantyh PW et al. (2002) Molecular mechanisms of cancer pain. Nat Rev Cancer 2: 201-209
16. Scholz J and Woolf CJ (2002) Can we conquer pain? Nat Neurosci 5 (Suppl): S1062-S1067
17. Dubner R (1991) Neuronal plasticity in the spinal and medullary dorsal horns: A possible role in central pain mechanisms. In Pain and central nervous disease: The central pain syndromes, 143-155 (Ed Casey KL) New York: Raven Press
18. Hunt SP and Mantyh PW (2001) The molecular dynamics of pain control. Nat Rev Neurosci 2: 83-91
19. Hill R (2000) NK1 (substance P) receptor antagonists - why are they not analgesic in human? Trends Pharmacol Sci 21: 244-246
20. Goldstein DJ et al. (2001) Dose-response study of the analgesic effect of lanepitant in patients with painful diabetic neuropathy. Clin Neuropharmacol 24: 16-22
21. Sindrup SH et al. (2005) The NK1 receptor antagonist TKA731 in painful diabetic neuropathy. A randomised controlled trial. Eur J Pain [doi:10.1016/j.ejpain.2005.08.001]
22. Fields HL (1990) Pain syndromes in neurology, 286. London: Butterworths
23. Jensen TS et al. (2001) The clinical picture of neuropathic pain. Eur J Pharmacol 429: 1-11
24. Koltzenburg M (1998) Painful neuropathies. Curr Opin Neurol 11: 515-521
25. Hansson P et al. (2001) Aspects of clinical and experimental neuropathic pain: The clinical perspective. In NeuropPthic pain: pathophysiology and treatment, progress in pain research and management, vol 21, 1-18 (Eds Hansson P et al.) Seattle: IASP Press
26. Woolf CJ and Max MB (2001) Mechanism-based pain diagnosis: Issues for analgesic drug development. Anesthesiology 95: 241-249
27. Jorum E et al. (2003) Cold allodynia and hyperalgesia in neuropathic pain: The effect of N-methyl-D-aspartate (NMDA) receptor antagonist ketamine - a double-blind, cross-over comparison with alfentanil and placebo. Pain 101: 229-235
28. Coderre TJ and Katz J (1997) Peripheral and central hyperexcitability: differential signs and symptoms in persistent pain. Behav Brain Sci 20: 404-419
29. Woolf CJ (2004) Dissecting out mechanisms responsible for peripheral neuropathic pain: Implications for diagnosis and therapy. Life Sci 74: 2605-2610
30. Scholz J et al. (2005) Blocking caspase activity prevents transsynaptic neuronal apoptosis and the loss of inhibition in lamina II of the dorsal horn after peripheral nerve injury. J Neurosci 10: 7317-7323
31. Le Bars D et al. (1992) Diffuse noxious inhibitory controls (DNIC) in animals and in man. Patol Fiziol Eksp Ter 1992 Jul-Aug: 55-65
32. Porreca F et al. (2002) Chronic pain and medullary descending facilitation. Trends Neurosci 25: 319-325
33. Ren K and Dubner R (2002) Descending modulation in persistent pain: An update. Pain 100: 1-6
34. Hansson PT and Dickenson AH (2005) Pharmacological treatment of peripheral neuropathic pain conditions based on shared commonalities despite multiple etiologies. Pain 113: 251-254
35. Leung A et al. (2001) Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain. Pain 91: 177-187
36. Otto M et al. (2003) Pain phenomena and possible mechanisms in patients with painful polyneuropathy. Pain 101: 187-192
37. Max MB et al. (1987) Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 37: 589-596
38. Sindrup SH et al. (2003) Venlafaxine versus imipramine in painful polyneuropathy: A randomized, controlled trial. Neurology 60: 1284-1289
39. Fields HL et al. (1998) Postherpetic neuralgia: Irritable nociceptors and deafferentation. Neurobiol Dis 5: 209-227
40. Rowbotham MC et al. (1996) Cutaneous innervation density in the allodynic form of postherpetic neuralgia. Neurobiol Dis 3: 205-214
41. Rowbotham MC and Fields HL (1996) The relationship of pain, allodynia and thermal sensation in post-herpetic neuralgia. Brain 119: 347-354
42. Petersen KL et al. (2000) Capsaicin evoked pain and allodynia in post-herpetic neuralgia. Pain 88: 125-133
43. Torebjork HE et al. (1992) Central changes in processing of mechanoreceptive input in capsaicin-induced secondary hyperalgesia in humans. J Physiol 448: 765-780
44. Gracely RH et al. (1992) Painful neuropathy: Altered central processing maintained dynamically by peripheral input. Pain 51: 175-194
45. Koltzenburg M et al. (1992) Dynamic and static components of mechanical hyperalgesia in human hairy skin. Pain 51: 207-219
46. Woolf CJ and Salter MW (2000) Neuronal plasticity: Increasing the gain in pain. Science 288: 1765-1769
47. Nurmikko T and Bowsher D (1990) Somatosensory findings in postherpetic neuralgia. J Neurol Neurosurg Psychiatry 53: 135-141
48. Baron R and Saguer M (1995) Mechanical allodynia in postherpetic neuralgia: Evidence for central mechanisms depending on nociceptive C-fiber degeneration. Neurology 45 (Suppl 8): S63-S65
49. Loeser JD et al. (1968) Chronic deafferentation of human spinal cord neurons. J Neurosurg 29: 48-50
50. Nakata Y et al. (1979) Supersensitivity to substance P after dorsal root section. Life Sci 24: 1651-1654
51. Basbaum AI and Wall PD (1976) Chronic changes in the response of cells in adult cat dorsal horn following partial deafferentation: The appearance of responding cells in a previously non-responsive region. Brain Res 116: 181-204
52. Rowbotham MC and Fields HL (1989) Topical lidocaine reduces pain in post-herpetic neuralgia. Pain 38: 297-301
53. Attal N et al. (1999) Effects of single and repeated applications of a eutectic mixture of local anaesthetics (EMLA) cream on spontaneous and evoked pain in post-herpetic neuralgia. Pain 81: 203-209
54. Rowbotham MC et al. (1995) Topical lidocaine gel relieves postherpetic neuralgia. Ann Neurol 37: 246-253
55. Rowbotham MC et al. (1996) Lidocaine patch: Double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain 65: 39-44
56. Wasner G et al. (2005) Postherpetic neuralgia: Topical lidocaine is effective in nociceptor-deprived skin. J Neurol 252: 677-686
57. Herrmann DN et al. (2005) Skin biopsy and quantitative sensory testing do not predict response to lidocaine patch in painful neuropathies. Muscle Nerve [doi:10.1002/mus.20419]
58. Finnerup NB et al. (2002) Lamotrigine in spinal cord injury pain: A randomized controlled trial. Pain 96: 375-383
59. Attal N et al. (2004) Systemic lidocaine in pain due to peripheral nerve injury and predictors of response. Neurology 62: 218-225
60. Finnerup NB et al. (2005) Intravenous lidocaine relieves spinal cord injury pain: A randomized controlled trial. Anesthesiology 102: 1023-1030
61. Wasner G et al. (2003) Complex regional pain syndrome - diagnostic, mechanisms, CNS involvement and therapy. Spinal Cord 41: 64-75
62. Raja SN et al. (1991) Systemic alpha-adrenergic blockade with phenolamine: A diagnostic test for sympathetically maintained pain. Anesthesiology 74: 691-698
63. Arner S (1991) Intraveneous phentolamine test: Diagnostic and prognostic use in reflex sympathetic dystrophy. Pain 46: 17-22
64. Rowbotham MC et al. (1991) Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology 41: 1024-1028
65. Baranowski AP et al. (1999) A trial of intravenous lidocaine on the pain and allodynia of postherpetic neuralgia. J Pain Symptom Manage 17: 429-433
66. Attal N et al. (2000) Intravenous lidocaine in central pain: A double-blind, placebo-controlled, psychophysical study. Neurology 54: 564-574
67. Wallace MS et al. (2000) Concentration-effect relationship of intravenous lidocaine on the allodynia of complex regional pain syndrome types I and II. Anesthesiology 92: 75-83
68. Meier T et al. (2003) Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: A randomized, double-blind, placebo-controlled study. Pain 106: 151-158
69. Wallace MS et al. (2000) Efficacy of oral mexiletine for neuropathic pain with allodynia: A double-blind, placebo-controlled, crossover study. Reg Anesth Pain Med 25: 459-467
70. Vestergaard K et al. (2001) Lamotrigine for central poststroke pain: A randomized controlled trial. Neurology 56: 184-190
71. Eide PK et al. (1994) Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: A double-blind, cross-over comparison with morphine and placebo. Pain 58: 347-354
72. Eide PK et al. (1995) Central dysesthesia pain after traumatic spinal cord injury is dependent on N-methyl-D-aspartate receptor activation. Neurosurgery 37: 1080-1087
73. Felsby S et al. (1996) NMDA receptor blockade in chronic neuropathic pain: A comparison of ketamine and magnesium chloride. Pain 64: 283-291
74. Max MB et al. (1995) Intravenous infusion of the NMDA antagonist, ketamine, in chronic posttraumatic pain with allodynia: A double-blind comparison to alfentanil and placebo. Clin Neuropharmacol 18: 360-368
75. Attal N et al. (2002) Effects of IV morphine in central pain: A randomized placebo-controlled study. Neurology 58: 554-563
76. Watson CP and Babul N (1998) Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology 50: 1837-1841
77. Watson CP et al. (2003) Controlled-release oxycodone relieves neuropathic pain: A randomized controlled trial in painful diabetic neuropathy. Pain 105: 71-78
78. Sindrup SH et al. (1999) The effect of tramadol in painful polyneuropathy in relation to serum drug and metabolite levels. Clin Pharmacol Ther 66: 636-641
79. Canavero S and Bonicalzi V (2004) Intravenous subhypnotic propofol in central pain: A double-blind, placebo-controlled, crossover study. Clin Neuropharmacol 27: 182-186
80. Yucel A et al. (2005) The effect of venlafaxine on ongoing and experimentally induced pain in neuropathic pain patients: A double blind, placebo controlled study. Eur J Pain 9: 407-416
81. McAdoo DJ et al. (1999) Changes in amino acid concentrations over time and space around an impact injury and their diffusion through the rat spinal cord. Exp Neurol 159: 538-544
82. Gwak YS and Hulsebosch CE (2005) Upregulation of Group I metabotropic glutamate receptors in neurons and astrocytes in the dorsal horn following spinal cord injury. Exp Neurol 195: 236-243
83. Liu J et al. (2004) Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury pain. Mol Ther 10: 57-66
84. v1.3 and functional involvement in neuronal hyperexcitability associated with central neuropathic pain after spinal cord injury. J Neurosci 23: 8881-8892